Cases & Deals

  • Home
  • Practices
  • IntegraGen closes €6.72 million private placement and subsequent IPO

Share

IntegraGen closes €6.72 million private placement and subsequent IPO

June 2010

Client(s) IntegraGen

Jones Day advised IntegraGen, a pioneer in the development of molecular diagnostic products and services, in connection with its €6.72 million (US$8.3 million) private placement to qualified investors, including BIOAM Gestion, CDC Enterprises, CDC Innovation, and IDInvest Partners, and subsequent initial public offering on the Alternext Market of NYSE Euronext Paris.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.